Literature DB >> 1372842

CD7 augments T cell proliferation via the interleukin-2 autocrine pathway.

L K Jung1, A K Roy, H R Chakkalath.   

Abstract

The role of CD7, a T cell differentiation antigen, in T cell function is not known at present; this study evaluates the effect of anti-CD7 mAb in PMBC cultures activated with suboptimal concentrations of lectins, antigens, and anti-CD3 mAb. We found that the inclusion of anti-CD7 resulted in increased IL-2 production and IL-2R-alpha expression in these cultures. H-7, a protein kinase C (PKC) inhibitor, and genistein, a protein tyrosine kinase (PTK) inhibitor, significantly suppressed the proliferation of T cells in comitogenic assays. This suggested that the comitogenic effect mediated by CD7 molecule involved both the PKC and the PTK pathways of T cell activation. These drugs appeared to affect the CD7-mediated effects by inhibiting the IL-2 autocrine pathway, especially the up-regulation of IL-2R-alpha since inhibition was not relieved with exogenous rIL-2. Taken together, our results suggest that CD7 augments T cell function by up-regulating IL-2R-alpha expression and IL-2 production via multiple pathways of protein phosphorylation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1372842     DOI: 10.1016/0008-8749(92)90138-f

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  4 in total

Review 1.  T cell signal transduction and the role of CD7 in costimulation.

Authors:  R Stillwell; B E Bierer
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

2.  K12/SECTM1, an interferon-γ regulated molecule, synergizes with CD28 to costimulate human T cell proliferation.

Authors:  Tao Wang; Catherine Huang; Alfonso Lopez-Coral; Kimberly A Slentz-Kesler; Min Xiao; E John Wherry; Russel E Kaufman
Journal:  J Leukoc Biol       Date:  2011-12-19       Impact factor: 4.962

3.  Expression of the CD7 ligand K-12 in human thymic epithelial cells: regulation by IFN-gamma.

Authors:  Gordon K Lam; Hua-Xin Liao; Yan Xue; S Munir Alam; Richard M Scearce; Russel E Kaufman; Gregory D Sempowski; Barton F Haynes
Journal:  J Clin Immunol       Date:  2005-01       Impact factor: 8.317

4.  CD7-deleted hematopoietic stem cells can restore immunity after CAR T cell therapy.

Authors:  Miriam Y Kim; Matthew L Cooper; Miriam T Jacobs; Julie K Ritchey; Julia Hollaway; Todd A Fehniger; John F DiPersio
Journal:  JCI Insight       Date:  2021-08-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.